caffeic acid has been researched along with Multiple Myeloma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hogan, L; Kim, MJ; Lassalle-Claux, G; Luiker, K; Murugesan, A; Reiman, T; Selka, A; Touaibia, M; Vaillancourt, E | 1 |
| Çiçek, SS; Galarza Pérez, M; Jöhrer, K; Kircher, B | 1 |
| Kuckling, D; Müller, M; Reis, B; Rust, T; Vehlow, D | 1 |
3 other study(ies) available for caffeic acid and Multiple Myeloma
| Article | Year |
|---|---|
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.
Topics: Angiogenesis Inhibitors; Apoptosis; Caffeic Acids; Cell Line, Tumor; Down-Regulation; Genes, myc; Humans; Ikaros Transcription Factor; Interferon Regulatory Factors; Lenalidomide; Multiple Myeloma; Phenylethyl Alcohol; Sp1 Transcription Factor; Structure-Activity Relationship | 2020 |
Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives from
Topics: Cell Line, Tumor; Flavones; Flavonols; Lamiaceae; Leukemia, Myeloid, Acute; Lignans; Multiple Myeloma; Phenols | 2022 |
Thermoresponsive Catechol Based-Polyelectrolyte Complex Coatings for Controlled Release of Bortezomib.
Topics: Bortezomib; Caffeic Acids; Catechols; Coated Materials, Biocompatible; Delayed-Action Preparations; Drug Delivery Systems; Humans; Methacrylates; Multiple Myeloma; Polyelectrolytes; Polymers | 2019 |